Blake Matrone’s Post

As part of Blu Ventures Trailblazers series, we sat down with Nick Delmonico, #CEO and #Founder of Strados Labs, a #RESP #Biosensor device company disrupting the respiratory health industry. Read more about Nick's journey from asthma-sufferer to founder of a #healthtech company that addresses respiratory health from the comfort of a patient's home, his experience with accelerators, lessons learned, and what is on the horizon for the company. https://lnkd.in/eWA6JHuj

Curious to hear Nick Delmonico's story of how he started Strados Labs? Read this enjoyable interview with our investor Blu Ventures that shares how he first came up with the idea for RESP, raised initial funding, received FDA 510(k) clearance, as well as lessons learned along the way. #healthtech #startup #founder #founderstories

We don't just say we are making a difference, we actually make it happen. 💪 See how Brainlab has made an impact since founded in 1989. Learn more about us here: https://lnkd.in/gRbTPjTs #medtech #WeAreBrainlab

Today, all 50 panel videos and 350+ presentation videos from LSI USA ‘24 went live on our website and YouTube channel. Revisit all your favorite moments from the event, or catch up on the ones you missed. We’d like to thank all of the incredible innovators dedicated to saving lives and improving patient outcomes, and to our panelists who continue to embrace our “un-panel” philosophy. Their challenging questions, valuable insights, and authentic conversations help us move Medtech forward, together. With #LSIEurope24 approaching fast, we're quickly filling our agenda. We’ve selected and announced our first batch of presenting companies, and confirmed investors from funds like Sofinnova Partners, Nina Capital, Panakes Partners, TVM Capital Life Science, Gilde Healthcare, Earlybird Venture Capital, and more across Europe, USA, APAC & the Middle East. If you're looking to connect with industry-leading investors (venture capital, private equity, angel groups, accelerators, etc.), then LSI Europe ‘24 is the place to do it. This event is expected to reach capacity much earlier than in previous years, so secure your spot today while space is still available. All videos available now: https://lnkd.in/gqE4fmfP

Creating $6.9b of investor value is reflective to the high quality of Octane’s company portfolio with many more to come over the next few years. Our quality dprocess, specifically with our Haystax diligence tool provide AI driven data for investors to make the most informed decision possible. Learn more at OctaneOC.org and our AI leadership.#AI #diligence #investor #nvidia #aimed #aileadership

We have another exiting partnership announcement 📢 for you. This time Zapyrus is partnering with Project Medtech, Duane Mancini, M. Sc. and his team. With this collaboration we hope to provide valuable insight into the minds of MedTech startup founders and CEOs. Helping you understand their challenges and successes. Connecting you to key networking opportunities in the MedTech space. #medtech #businessdevelopment

If you're stuck at this stage & don't know what your next step should be, check out this blog by the Director of our 1099 Accelerator Program: https://lnkd.in/gN8dJqeg #Medtech #MedicalDevice #1099

Have a New Year's resolution to save time and money? Transform your clinical trial processes with PROPEL and your organization could save nearly 30 hours per week! According to an analysis by one of our leading IRO clients, PROPEL saves their organization an average of 29.7 hours per week (based on 100 new trial activations a year). Accelerate clinical trial processes, automate study startup, respond to more trial opportunities, and save time and money across the board with PROPEL! Get started today! https://lnkd.in/gdvqY4ZP #resolution #clinicaltrials #clinicalresearch #clinicaltrialsoftware #PROPEL

Looking at the future of cardiac care, how can major device companies collaborate with the startup ecosystem? In this clip Chris Eso, Vice President, Global Head of Corporate and Business Development, M&A and Ventures at Medtronic, predicts that in the next 10-20 years, medical devices will be highly interconnected and data-driven. This shift marks a significant shift from traditional Medtech. Achieving this level of connectivity will require extensive collaboration between major device companies and the startup ecosystem. The full panel shares insights on fostering successful partnerships, enhancing patient care, and driving the next wave of breakthroughs in cardiac treatment and management. Tune into the full panel “Accelerating Cardiac Care Innovation: How Can Major Device Companies Collaborate with the Startup Ecosystem?” to hear more from Ken Nelson, Nate Harrington, Lisa Suennen, GCB.D, Chris Eso, and David Hochman.

Have a New Year's resolution to save time and money? Transform your clinical trial processes with PROPEL and your organization could save nearly 30 hours per week! According to an analysis by one of our leading IRO clients, PROPEL saves their organization an average of 29.7 hours per week (based on 100 new trial activations a year). Accelerate clinical trial processes, automate study startup, respond to more trial opportunities, and save time and money across the board with PROPEL! Get started today! https://lnkd.in/e5WNVw7C #resolution #clinicaltrials #clinicalresearch #clinicaltrialsoftware #PROPEL